Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 23, 2025, titled "Eugia Pharma receives USFDA approval for Dasatinib Tablets".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 23, 2025, titled "Eugia Pharma receives USFDA approval for Dasatinib Tablets".